| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Regenxbio Inc. (RGNX) has 14 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. RGNX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 495.9K | $4.50M | - | |
| CEO | 342.5K | $3.11M | - | |
| Other | 247.9K | $2.25M | - | |
| Other | 215.4K | $1.95M | - | |
| Other | 82.2K | $745.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 7, 2017 | Simpson Curran66 | SVP, Technical Operations | Sale+OE | 21,890 | $30.04 | $657,575.60 | -35.7% | |
| Dec 4, 2017 | Simpson Curran66 | SVP, Technical Operations | Sale+OE | 110 | $30.00 | $3,300.00 | -0.3% | |
| Nov 27, 2017 | Simpson Curran66 | SVP, Technical Operations | Sale+OE | 2,000 | $29.31 | $58,620.00 | -4.8% | |
| Nov 20, 2017 | Mills Kenneth T.81 | President And CEO | Sale+OE | 10,000 | $27.71 | $277,100.00 | -7.8% | |
| Nov 15, 2017 | Vasista Vittal79 | Chief Financial Officer | Sell | 5,000 | $25.30 | $126,500.00 | -5.4% | |
| Oct 20, 2017 | Mills Kenneth T.81 | President And CEO | Sell | 10,000 | $32.62 | $326,184.00 | -4.8% | |
| Oct 16, 2017 | Vasista Vittal79 | Chief Financial Officer | Sell | 5,000 | $33.25 | $166,250.00 | -5.1% | |
| Oct 11, 2017 | Hayden Donald J Jr | Director | Sale+OE | 20,000 | $34.95 | $699,000.00 | -100% | |
| Sep 27, 2017 | Hayden Donald J Jr | Director | Sale+OE | 20,000 | $32.45 | $649,000.00 | -100% | |
| Sep 20, 2017 | Mills Kenneth T.81 | President And CEO | Sell | 10,000 | $29.33 | $293,273.00 | -4.4% |